Skip to main content

Peer Review reports

From: Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development

Original Submission
3 Jun 2020 Submitted Original manuscript
3 Jul 2020 Reviewed Reviewer Report
23 Jul 2020 Reviewed Reviewer Report
24 Jul 2020 Reviewed Reviewer Report
10 Aug 2020 Author responded Author comments - Jennifer Sarah Davis
Resubmission - Version 2
10 Aug 2020 Submitted Manuscript version 2
14 Aug 2020 Author responded Author comments - Jennifer Sarah Davis
Resubmission - Version 3
14 Aug 2020 Submitted Manuscript version 3
Publishing
17 Aug 2020 Editorially accepted
10 Sep 2020 Article published 10.1186/s12885-020-07311-4

You can find further information about peer review here.

Back to article page